Charity profile · Historical source record

Rett Syndrome Research Trust

EIN 26-0687439Health Connecticut Mid-sized

Historical collection: May 2019 · Rating details mostly from 2017. Source & context

The mission

What this organization describes

Making Rett History

RSRT was launched in 2008 to drive research toward a cure for Rett Syndrome and related MECP2 disorders. Our mission is urgent: 15,000 girls and women in the US and 350,000 globally live with the agonizing symptoms of Rett Syndrome.

Mission and tagline reproduced from the source record.

Historical scorecard

Three perspectives. One record.

82.96Overall score
out of 100

75.91Financial score
out of 100

100.00Accountability & transparency
out of 100

These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗

Financial context

Revenue, expenses, and composition

Total revenue · USD$12,528,990

Total expenses · USD$7,443,444

Program expenses

$6,929,846.36 recorded amount

93.1%

Fundraising expenses

$372,172.20 recorded amount

5.0%

Administrative expenses

$126,538.55 recorded amount

1.7%

Fundraising efficiency: $0.04 spent per $1 raised in donations, as defined in the source.

Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗

Historical leadership record

The leadership information supplied

Recorded leader: Monica Coenraads
Recorded compensation: $165,000.00
Recorded compensation percentage: 2.21%

These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗

Inspect all 23 original source fields

Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.

All 23 original fields for Rett Syndrome Research Trust
Source field	Original source value
`ascore` Accountability & transparency score	100.0
`category` Category	Health
`description` Mission & description	RSRT was launched in 2008 to drive research toward a cure for Rett Syndrome and related MECP2 disorders. Our mission is urgent: 15,000 girls and women in the US and 350,000 globally live with the agonizing symptoms of Rett Syndrome.
`ein` EIN	26-0687439
`tot_exp` Total expenses	7443444.0
`admin_exp_p` Administrative expense fraction	0.017
`fund_eff` Fundraising efficiency ($ per $1 raised)	0.04
`fund_exp_p` Fundraising expense fraction	0.05
`program_exp_p` Program expense fraction	0.9309999999999999
`fscore` Financial score	75.91
`leader` Recorded leader	Monica Coenraads
`leader_comp` Recorded leader compensation	165000.0
`leader_comp_p` Recorded leader compensation fraction	0.022099999999999998
`motto` Tagline	Making Rett History
`name` Charity name	Rett Syndrome Research Trust
`tot_rev` Total revenue	12528990.0
`score` Overall score	82.96
`state` State code	CT
`subcategory` Subcategory	Medical Research
`size` Source size label	mid
`program_exp` Program expenses	6929846.363999999
`fund_exp` Fundraising expenses	372172.2
`admin_exp` Administrative expenses	126538.54800000001

Identity & classification

At a glance

EIN: 26-0687439
Source category: Health
Source subcategory: Medical Research
Recorded location: Connecticut (CT)
Expense-based size: Mid-sized
$3.5M–$13.5M in total expenses · source label: mid

Explore alongside

Related source records

Linked by source subcategory, prioritizing the same recorded state. Not a recommendation or ranking.

A useful next step

Keep the context.

Check current organizational information separately before making a giving decision. This record does not include an official website, donation URL, or current eligibility field.

Giving research guide ↗

Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.